Enzolytics Inc (ENZC)

[Timing101]

veloyt..
--
Yes you are correct those are NEW Series B Preferred shares and described that way as being "newly issued" in the disclosure.
https://backend.otcmarkets.com/otcapi/company/financial-report/265788/content
Quote
"Business Combination Agreement with Bioclonetics Immunotherapeutics, Inc. Resulting in
Change of Control
On November 30, 2020, Enzolytics, Inc. (the “Company”) entered into a Business Combination
Agreement with Bioclonetics Immunotherapeutics, Inc., (“Bioclonetics”) a Texas Corporation
controlled by Charles S. Cotropia, the Company’s current Chief Executive Officer.
As consideration for the Business Combination, and in exchange for 100% of the issued and
outstanding stock of BioClonetics, the Company has agreed to issue a total of 204,430,000 newly
issued shares of Series B Preferred Stock to Charles S. Cotropia, and others Bioclonetics Designees
and 90,570,000 shares of newly issued Series B Preferred Stock to Harry Zhabilov, the Company’s
current Chief Financial Officer"
--
The Question of "How does this help us" as the Shareholder I take it .
--
a. Not sure it helps but it was part of the MERGER DEAL, so it is what it is . They are New, but they are "Restricted" so come with rules on them and as ct808 said in his post, someone that got them would have to wait at least a Year. In a Year from now .. it will be interesting to see what ENZC evolves into . They are new, so they add to the TOTAL and one would imagine it would be shown on any update past Nov 30, 2020 of the Share Structure.
-
b. Charles C will use those as PREFERRED SHARES, that go to the original Bioclonetics Investors (as ct808 explained in his post on the email he got from Charles being an original investor through WeFunder).
--
c. With that being the case, there should be no dilution until such time ( at least a year from now and it will be whole different ball game then , hopefully X Times the growth of the PPS Price) until they convert those preferred shares .
--
d. The biggest part of hearing this of course , is Charles C as a CEO , ATTORNEY and being held to follow regulations is that .
He would have to have possession of Such Shares before he made a certified and quantified offer to the original Bioclonetics Investors and would not do so , if it was not Legal.
To be legal, then means that the Block Transfer of Shares at least to Charles and Harry , plus the 'certain designated Bioclonetics" (their shares in trust held by Charles Z ) is completed to do so .
---
TIME will Tell shortly , we are so, so close to the next adventure here. Every time there is a disclosure , it is off the plate and moves to the next one . Will be happy to see it current and just starting to fire on all cylinder's of this motor.
The way Charles set up the other Two Corporations for the Licensing would indicate there is a DEMAND , so lets see it happen.